BCG priming followed by a novel interleukin combination activates Natural Killer cells to selectively proliferate and become anti-tumour long-lived effectors
Resumen: The short-lived nature and heterogeneity of Natural Killer (NK) cells limit the development of NK cell-based therapies, despite their proven safety and efficacy against cancer. Here, we describe the biological basis, detailed phenotype and function of long-lived anti-tumour human NK cells (CD56highCD16+), obtained without cell sorting or feeder cells, after priming of peripheral blood cells with Bacillus Calmette-Guérin (BCG). Further, we demonstrate that survival doses of a cytokine combination, excluding IL18, administered just weekly to BCG-primed NK cells avoids innate lymphocyte exhaustion and leads to specific long-term proliferation of innate cells that exert potent cytotoxic function against a broad range of solid tumours, mainly through NKG2D. Strikingly, a NKG2C+CD57-FcεRIγ+ NK cell population expands after BCG and cytokine stimulation, independently of HCMV serology. This strategy was exploited to rescue anti-tumour NK cells even from the suppressor environment of cancer patients’ bone marrow, demonstrating that BCG confers durable anti-tumour features to NK cells.
Idioma: Inglés
DOI: 10.1038/s41598-024-62968-2
Año: 2024
Publicado en: Scientific reports (Nature Publishing Group) 14, 1 (2024), 16 pp.
ISSN: 2045-2322

Financiación: info:eu-repo/grantAgreement/ES/AEI/PID2020-115506RB-I00
Financiación: info:eu-repo/grantAgreement/ES/MCINN/PID2021-123795OB-I00
Tipo y forma: Article (Published version)
Área (Departamento): Área Inmunología (Dpto. Microb.Ped.Radio.Sal.Pú.)

Creative Commons You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.


Exportado de SIDERAL (2024-06-19-13:22:38)


Visitas y descargas

Este artículo se encuentra en las siguientes colecciones:
Articles



 Record created 2024-06-19, last modified 2024-06-19


Versión publicada:
 PDF
Rate this document:

Rate this document:
1
2
3
 
(Not yet reviewed)